Recitovat žádoucí směs mature.nl miska 56 sát Marine Zapojte se
Miska Group – Wellcome Sanger Institute
Miska Group – Wellcome Sanger Institute
Frontiers | OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications
Standardized and reproducible measurement of decision-making in mice | eLife
Miska, Eric – Wellcome Sanger Institute
miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms - ScienceDirect
microRNA - Wikipedia
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy | Physiological Reviews
Epigenetic Aspects and Prospects in Autoimmune Hepatitis - Frontiers
Biomedicines | Free Full-Text | A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 | HTML
Miska Group – Wellcome Sanger Institute
Single paternal dexamethasone challenge programs offspring metabolism and reveals multiple candidates in RNA-mediated inheritance - ScienceDirect
DEPS-1 is required for piRNA-dependent silencing and PIWI condensate organisation in Caenorhabditis elegans | Nature Communications
IJERPH | Free Full-Text | MiRNA: Biological Regulator in Host-Parasite Interaction during Malaria Infection | HTML
World Screen MIPTV 2019 by World Screen - Issuu
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cancers | Free Full-Text | Lin28 Regulates Cancer Cell Stemness for Tumour Progression | HTML
Miska Group – Wellcome Sanger Institute
Taming transposable elements in vertebrates: from epigenetic silencing to domestication: Trends in Genetics
The RNA polymerase II subunit RPB‐9 recruits the integrator complex to terminate Caenorhabditis elegans piRNA transcription | The EMBO Journal
The RNA Polymerase II core subunit RPB-9 directs transcriptional elongation at piRNA loci in Caenorhabditis elegans | bioRxiv
Miska Group – Wellcome Sanger Institute
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications